{"DataElement":{"publicId":"2182826","version":"2","preferredName":"Actual Dose Amount","preferredDefinition":"The amount that describes how much of the agent was actually taken.","longName":"AGT_ACTL_AMT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2013049","version":"3","preferredName":"Actual Dose Administered","preferredDefinition":"Amount of medicine taken, or radiation given, within one dose.","longName":"ACTUAL_DOSE","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2206416","version":"1","preferredName":"Actual Dose","preferredDefinition":"Existing in fact; real. (from American Heritage Dictionary):The amount of medicine taken, or radiation given, at one time.","longName":"C25274:C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Actual","conceptCode":"C25274","definition":"Existing in fact; real.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F46E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177665","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"Administered","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-516D-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7B68E0E-1ED2-38ED-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182817","version":"2","preferredName":"Agent Provided Amount","preferredDefinition":"The total quantity or number used to describes the amount of agent dispensed.","longName":"AGT_PROV_AMT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"ALPHANUMERIC","minLength":"1","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":"4","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2636904","version":"1","preferredName":"Agent Dispense Amount","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI):No Value Exists:The total quantity or number.","longName":"C1708:C64658:C25417","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dispense","conceptCode":"C64658","definition":"Give or apply.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Amount","conceptCode":"C25417","definition":"The total quantity or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA13C3-884C-03D7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-05-08","modifiedBy":"ONEDATA","dateModified":"2007-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF894AC-85B0-68BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-05-08","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812152","version":"1","longName":"Barretts Esophagus - ASA-Esomeprazole","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812102","version":"1","longName":"Budesonide Lung Nodules","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812843","version":"1","longName":"Polyethylene Glycol - Colon Carcinogenesis","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2859628","version":"1","longName":"Breast Sulindac DFMO","context":"DCP"},{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4111771","version":"1","longName":"UWI2013-00-01","context":"DCP"},{"publicId":"5981652","version":"1","longName":"UAZ2017-09-02","context":"DCP"},{"publicId":"5889177","version":"1","longName":"MDA2016-08-02","context":"DCP"},{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"},{"publicId":"3896538","version":"1","longName":"UAZ2013-01-01","context":"DCP"},{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"},{"publicId":"4261112","version":"1","longName":"UAZ2013-02-01","context":"DCP"},{"publicId":"4261412","version":"1","longName":"MDA2013-01-01","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"4528054","version":"1","longName":"NWU2013-01-03","context":"DCP"},{"publicId":"5416571","version":"1","longName":"MDA2013-02-02","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"},{"publicId":"5889185","version":"1","longName":"UWI2016-08-01","context":"DCP"},{"publicId":"5280812","version":"1","longName":"NWU2015-06-01","context":"DCP"},{"publicId":"6046252","version":"1","longName":"UAZ2016-08-02","context":"DCP"},{"publicId":"5280811","version":"1","longName":"NWU2014-04-01","context":"DCP"},{"publicId":"5280814","version":"1","longName":"NWU2015-06-03","context":"DCP"},{"publicId":"5889179","version":"1","longName":"NWU2016-08-02","context":"DCP"},{"publicId":"5889178","version":"1","longName":"MDA2017-09-03","context":"DCP"},{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"},{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"},{"publicId":"5889176","version":"1","longName":"MDA2016-07-02","context":"DCP"},{"publicId":"5280815","version":"1","longName":"NWU2015-06-04","context":"DCP"},{"publicId":"4528056","version":"1","longName":"NWU2013-02-01","context":"DCP"},{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"DCP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Dispense Amount","type":"Preferred Question Text","description":"Dispense Amount","url":null,"context":"DCP"},{"name":"Amount of agent taken this period","type":"Alternate Question Text","description":"Amount of agent taken this period","url":null,"context":"DCP"},{"name":"Amount of agent taken during this period","type":"Alternate Question Text","description":"Amount of agent taken during this period","url":null,"context":"DCP"},{"name":"Amount of agent used during this period","type":"Alternate Question Text","description":"Amount of agent used during this period","url":null,"context":"DCP"},{"name":"Amount of agent taken","type":"Alternate Question Text","description":"Amount of agent taken","url":null,"context":"DCP"},{"name":"DCP CRF Question","type":"Alternate Question Text","description":"Amount of agent used during this period (# of capsules)","url":null,"context":"DCP"},{"name":"DCP CRF Text","type":"Alternate Question Text","description":"Amount of agent used during this period (# of tablet)","url":null,"context":"DCP"},{"name":"DCP Text -7","type":"Alternate Question Text","description":"Amount of agent used during this period (# of pills)","url":null,"context":"DCP"},{"name":"DCP-Text-8","type":"Alternate Question Text","description":"Amount of agent taken during this period (capsules)","url":null,"context":"DCP"},{"name":"DCP-Text-9","type":"Alternate Question Text","description":"Amount of agent used during this period (# of vials)","url":null,"context":"DCP"},{"name":"DCP Text 10","type":"Alternate Question Text","description":"Number of tablets taken during this period","url":null,"context":"DCP"},{"name":"DCP-Text-11","type":"Alternate Question Text","description":"Amount of agent applied during this period (grams)","url":null,"context":"DCP"},{"name":"DCP-Text-12","type":"Alternate Question Text","description":"Amount of agent taken during this period (Tablets)","url":null,"context":"DCP"},{"name":"DCP-Text-13","type":"Alternate Question Text","description":"Number of tablets expected to have been taken during this period","url":null,"context":"DCP"},{"name":"DCP-Text-16","type":"Alternate Question Text","description":"Amount of agent used during this period (# of pills according to pill count)","url":null,"context":"DCP"},{"name":"DCP-Text-15","type":"Alternate Question Text","description":"Amount of Metformin used during this period (# of pills according to pill count)","url":null,"context":"DCP"},{"name":"DCP-Text-14","type":"Alternate Question Text","description":"Amount of Megestrol Acetate used during this period (# of pills according to pill count)","url":null,"context":"DCP"},{"name":"DCP CRF TEXT 17","type":"Alternate Question Text","description":"Number of Pills Taken During This Period","url":null,"context":"DCP"},{"name":"DCP CRF TEXT 18","type":"Alternate Question Text","description":"Number of Pills Taken During This Period (according to pill count)","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E827E4B5-C9EF-2BA9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-05","modifiedBy":"MMADDINENI","dateModified":"2023-05-18","changeDescription":null,"administrativeNotes":"03/22/2023-Added AQT for DCP SVAR Template-MM","unresolvedIssues":null,"deletedIndicator":"No"}}